Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function

J. Maspero (Buenos Aires, Argentina), D. Halpin (Exeter, United Kingdom), D. Jackson (London, United Kingdom), N. Hanania (Houston, United States of America), M. Castro (Kansas City, United States of America), C. Domingo (Barcelona, Spain), N. Daizadeh (Cambridge, United States of America), M. Djandji (Cambridge, United States of America), P. Rowe (Bridgewater, United States of America), Y. Deniz (Tarrytown, United States of America)

Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma
Session: Recent innovations regarding the mechanisms and treatments of asthma
Session type: Oral Presentation
Number: 5282

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Maspero (Buenos Aires, Argentina), D. Halpin (Exeter, United Kingdom), D. Jackson (London, United Kingdom), N. Hanania (Houston, United States of America), M. Castro (Kansas City, United States of America), C. Domingo (Barcelona, Spain), N. Daizadeh (Cambridge, United States of America), M. Djandji (Cambridge, United States of America), P. Rowe (Bridgewater, United States of America), Y. Deniz (Tarrytown, United States of America). Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function. 5282

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: